Clinical Trials · NCT01754818
A Phase 1 Study Examining the Pharmacokinetics and Tolerability of a Single Oral Dose of Bendavia (MTP-131)
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 30
- Start date
- Nov 2012
- Locations
- 1 site, United States
- Primary endpoint
- Mean peak plasma concentration (Cmax) of Bendavia (ng/ml) in each cohort.